The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro - Concepedia

Concepedia

Publication | Open Access

The combination of an mTORc1/TORc2 inhibitor with lapatinib is synergistic in bladder cancer in vitro

DOI Full Paper Access

28

Citations

29

References

2013

Year

Marie N. Becker, Kevin J. Wu, Laura A. Marlow, Pamela Kreinest, Christina A. Von Roemeling, John A. Copland, Christopher Williams

Urologic Oncology Seminars and Original Investigations

UrologyGenitourinary CancerMedicinePharmacologyMtorc1/torc2 InhibitorAnti-cancer AgentCancer TreatmentOncology

References

	Year	Citations

Page 1